Relmada Therapeutics shares owned by Bedel Financial Consulting
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Bedel Financial Consulting
from 13F filings
Historical chart of Bedel Financial Consulting investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Bedel Financial Consulting consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Relmada Therapeutics by Bedel Financial Consulting
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $20k | 10k | 2.01 |
| 2025-06-30 | $6.0k | 10k | 0.60 |
| 2025-03-31 | $3.6k | 10k | 0.36 |
| 2024-12-31 | $3.8k | 10k | 0.38 |
| 2024-09-30 | $32k | 10k | 3.24 |
| 2024-06-30 | $30k | 10k | 3.00 |
| 2024-03-31 | $47k | 10k | 4.65 |
| 2023-12-31 | $41k | 10k | 4.14 |
| 2023-09-30 | $30k | 10k | 3.00 |
| 2023-06-30 | $25k | 10k | 2.46 |
More positions owned by Bedel Financial Consulting
View all positions for Bedel Financial Consulting